Investing.com - Galapagos ADR reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Galapagos ADR announced earnings per share of $-1.83 on revenue of $317.9M. Analysts polled by Investing.com anticipated EPS of $-1.57 on revenue of $117.97M.
Galapagos ADR shares are down 43.79% from the beginning of the year and are trading at $55.64 , down-from-52-week-high.They are under-performing the Nasdaq which is up 23.68% from the start of the year.
Galapagos ADR follows other major Healthcare sector earnings this month
Galapagos ADR's report follows an earnings beat by Merck&Co on Thursday, October 28, 2021, who reported EPS of $1.75 on revenue of $13.15B, compared to forecasts EPS of $1.55 on revenue of $12.32B.
Danaher had beat expectations on Thursday, October 21, 2021 with third quarter EPS of $2.39 on revenue of $7.23B, compared to forecast for EPS of $2.15 on revenue of $7B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar